Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-02

Clinical Trial Update: The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) [Phase 2]

View source ↗

Summary

Phase 2 trial update on the pharmacokinetics of anagrelide in elderly and young patients with essential thrombocythemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANAGRELIDE (Anagrelide)

Snippet

Sponsor: Shire | Conditions: Essential Thrombocythaemia | Phase 2 | Status: COMPLETED | Results posted: 2009-06-02